Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis.
about
Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Single-agent PARP inhibitors f ...... atic review and meta-analysis.
@en
Single-agent PARP inhibitors f ...... atic review and meta-analysis.
@nl
type
label
Single-agent PARP inhibitors f ...... atic review and meta-analysis.
@en
Single-agent PARP inhibitors f ...... atic review and meta-analysis.
@nl
prefLabel
Single-agent PARP inhibitors f ...... atic review and meta-analysis.
@en
Single-agent PARP inhibitors f ...... atic review and meta-analysis.
@nl
P2093
P2860
P50
P1433
P1476
Single-agent PARP inhibitors f ...... matic review and meta-analysis
@en
P2093
Benedetta Conte
Christian Maurer
Francesca Poggio
Giulia Viglietti
Lucia Del Mastro
Samuel Martel
P2860
P304
P356
10.1136/ESMOOPEN-2018-000361
P577
2018-06-20T00:00:00Z